Education
About Us
Working with TipRanks
Follow Us
Beijing Luzhu Biotechnology Co., Ltd. Class H (HK:2480)
:2480
2480 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$20.00 - HK$28.00
Previous CloseN/A
Volume1.00K
Average Volume (3M)22.29K
Market Cap
N/A
Enterprise ValueHK$4.60B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Mar 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.42
Shares Outstanding202,449,040
10 Day Avg. Volume7,020
30 Day Avg. Volume22,293
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Beijing Luzhu Biotechnology Co., Ltd. Class H News
2480 FAQ
What was Beijing Luzhu Biotechnology Co., Ltd. Class H’s price range in the past 12 months?
Beijing Luzhu Biotechnology Co., Ltd. Class H lowest stock price was HK$20.00 and its highest was HK$28.00 in the past 12 months.
What is Beijing Luzhu Biotechnology Co., Ltd. Class H’s market cap?
Currently, no data Available
When is Beijing Luzhu Biotechnology Co., Ltd. Class H’s upcoming earnings report date?
Beijing Luzhu Biotechnology Co., Ltd. Class H’s upcoming earnings report date is Mar 13, 2026 which is in 155 days.
How were Beijing Luzhu Biotechnology Co., Ltd. Class H’s earnings last quarter?
Beijing Luzhu Biotechnology Co., Ltd. Class H released its earnings results on Aug 26, 2025. The company reported -HK$0.425 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.425.
Is Beijing Luzhu Biotechnology Co., Ltd. Class H overvalued?
According to Wall Street analysts Beijing Luzhu Biotechnology Co., Ltd. Class H’s price is currently Overvalued.
Does Beijing Luzhu Biotechnology Co., Ltd. Class H pay dividends?
Beijing Luzhu Biotechnology Co., Ltd. Class H does not currently pay dividends.
What is Beijing Luzhu Biotechnology Co., Ltd. Class H’s EPS estimate?
Beijing Luzhu Biotechnology Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beijing Luzhu Biotechnology Co., Ltd. Class H have?
Beijing Luzhu Biotechnology Co., Ltd. Class H has 202,449,040 shares outstanding.
What happened to Beijing Luzhu Biotechnology Co., Ltd. Class H’s price movement after its last earnings report?
Beijing Luzhu Biotechnology Co., Ltd. Class H reported an EPS of -HK$0.425 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.643%.
Which hedge fund is a major shareholder of Beijing Luzhu Biotechnology Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2480
Technical Analysis
Clover Biopharmaceuticals Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―
Tycoon Group Holdings Limited
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―
Biosino Bio-Technology & Science, Inc. Class H
―